| Authors: |
Bick MV; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Puig E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Beauparlant D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Nedellec R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Burton I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Ardaghi K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Zalunardo TR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Bastidas R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Li X; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA., Guenaga J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92109, USA., Wyatt R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA., Zhu W; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Crispin M; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92109, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92109, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA., Hangartner L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92109, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: lhangart@scripps.edu. |
